Synapse

← Cancer Research Communications

Papers in Cancer Research Communications

Page 8 · newest first

  1. Branched-Chain Amino Acid Catabolism Promotes Ovarian Cancer Cell Proliferation via Phosphorylation of mTORCancer Research Communications · 2025
  2. LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical DevelopmentCancer Research Communications · 2025
  3. IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian CancerCancer Research Communications · 2025
  4. 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationCancer Research Communications · 2025
  5. OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor–Associated Arthralgia SusceptibilityCancer Research Communications · 2025
  6. Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineCancer Research Communications · 2025
  7. Identification of Causal Plasma Proteins in Hepatocellular Carcinoma via Two-Sample Mendelian Randomization and Integrative Transcriptomic‒Proteomic AnalysisCancer Research Communications · 2025
  8. Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsCancer Research Communications · 2025
  9. A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell FunctionCancer Research Communications · 2025
  10. Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid CancerCancer Research Communications · 2025
  11. Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial CarcinomaCancer Research Communications · 2025
  12. Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA LaboratoryCancer Research Communications · 2025
  13. Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid TumorsCancer Research Communications · 2025
  14. Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical StudyCancer Research Communications · 2025
  15. Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic MelanomaCancer Research Communications · 2025
  16. A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersCancer Research Communications · 2025
  17. Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral ImmunotherapyCancer Research Communications · 2025
  18. Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic TargetingCancer Research Communications · 2025
  19. PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian CarcinomaCancer Research Communications · 2025
  20. Age at First Full-term Pregnancy and Other Reproductive Factors Are Associated with Mammographic Breast Density in Postmenopausal Women: A Study in Flanders, BelgiumCancer Research Communications · 2025
  21. Development of a Microvessel Density Gene Signature and Its Application in Precision MedicineCancer Research Communications · 2025
  22. A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain–Liver Metastasis AxisCancer Research Communications · 2025
  23. MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian CancerCancer Research Communications · 2025
  24. Real-World Incidence of Anaplastic Lymphoma Kinase Alterations in Hispanics with Non–Small Cell Lung Cancer at a Large Academic Institution in Los AngelesCancer Research Communications · 2025
  25. Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT TrialsCancer Research Communications · 2025
  26. The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRAS G12C Inhibitors in Preclinical ModelsCancer Research Communications · 2025
  27. Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early RecurrenceCancer Research Communications · 2025
  28. Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann CellsCancer Research Communications · 2025
  29. Analysis of Urban Indian Organizations’ Promotion of Cancer ServicesCancer Research Communications · 2025
  30. Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaCancer Research Communications · 2025
  31. Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated FibroblastsCancer Research Communications · 2025
  32. Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A SurveyCancer Research Communications · 2025
  33. Deep Learning Predicts Subtype Heterogeneity and Outcomes in Luminal A Breast Cancer Using Routinely Stained Whole-Slide ImagesCancer Research Communications · 2024
  34. A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection in High-Risk PopulationsCancer Research Communications · 2024
  35. Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment StrategiesCancer Research Communications · 2024
  36. Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR - and KRAS -Mutant Lung CancerCancer Research Communications · 2024
  37. Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene ExpressionCancer Research Communications · 2024
  38. Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White PatientsCancer Research Communications · 2024
  39. The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric CancerCancer Research Communications · 2024
  40. Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid LeukemiaCancer Research Communications · 2024
  41. Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal CancerCancer Research Communications · 2024
  42. First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesCancer Research Communications · 2024
  43. Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 PathwayCancer Research Communications · 2024
  44. Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid TumorsCancer Research Communications · 2024
  45. Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung CancerCancer Research Communications · 2024
  46. Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical TrialsCancer Research Communications · 2024
  47. Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell SurvivalCancer Research Communications · 2024
  48. Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient CancersCancer Research Communications · 2024
  49. Depletion of Adipose Stroma-Like Cancer-Associated Fibroblasts Potentiates Pancreatic Cancer ImmunotherapyCancer Research Communications · 2024
  50. Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced ImmunosuppressionCancer Research Communications · 2024